Department of Endocrinology-Diabetology-Nutrition, Paris-Nord University, CRNH-IdF, Paris-13 University, Sorbonne Paris Cité, AP-HP, Jean-Verdier Hospital, avenue du 14-Juillet, 93143 Bondy cedex, France.
Diabetes Metab. 2013 Apr;39(2):118-25. doi: 10.1016/j.diabet.2012.08.013. Epub 2012 Dec 4.
This study assessed whether the poor correlation between HbA1c and oral glucose tolerance test (OGTT) for dysglycaemia diagnosis may be explained by haemoglobin glycation (HbG).
A total of 1033 consecutive overweight or obese patients with no known diabetes underwent OGTT and measurement of HbA1c to diagnose diabetes and dysglycaemia (American Diabetes Association criteria). For each OGTT result category, low, medium and high HbG was defined according to the mean HbA1c/fructosamine ratio and mean fructosamine. High HbG was defined as values greater than mean values in each OGTT category for both HbA1c/fructosamine ratio and fructosamine levels, and low HbG was defined as lower values of both. The remaining patients were considered medium HbG.
Based on OGTT and HbA1c values, 267 (25.8%) and 443 (42.8%) patients had intermediate hyperglycaemia, and 66 (6.4%) and 95 (9.2%) patients had diabetes, respectively. The results were discordant for intermediate hyperglycaemia or diabetes diagnosis in 41.7% and for diabetes diagnosis in 10.0% of the patients. The proportion of patients with HbA1c≥6.5%, but without OGTT-diagnosed diabetes, was 0%, 3.8% and 32.8% in the low-HbG, medium-HbG and high-HbG groups, respectively. In contrast, the proportion of patients with HbA1c<5.7%, but with an abnormal OGTT, was 30.4%, 11.1% and 0%, respectively. The AUROC of HbA1c to detect OGTT-diagnosed diabetes was better in the medium-HbG group [0.874 (0.816-0.931)] than in those with low or high HbG [0.628 (0.489-0.768); P<0.01]. Only age was independently associated with high-HbG status [10-year OR: 1.3 (1.1-1.5); P<0.0001].
Haemoglobin glycation may explain many of the discordant results between HbA1c and OGTT when used for dysglycaemia diagnosis.
本研究旨在评估糖化血红蛋白(HbA1c)与口服葡萄糖耐量试验(OGTT)在诊断糖代谢异常方面的相关性较差是否可以用血红蛋白糖化(HbG)来解释。
共纳入 1033 例连续超重或肥胖、无已知糖尿病的患者,进行 OGTT 和 HbA1c 测量以诊断糖尿病和糖代谢异常(美国糖尿病协会标准)。根据 HbA1c/果糖胺比值和果糖胺水平的平均值,将每个 OGTT 结果类别中的低、中、高 HbG 定义为低、中、高 HbG。高 HbG 定义为 HbA1c/果糖胺比值和果糖胺水平在每个 OGTT 类别中的值均大于平均值,低 HbG 定义为两者均较低。其余患者被认为是中 HbG。
根据 OGTT 和 HbA1c 值,267(25.8%)和 443(42.8%)例患者存在中等程度高血糖,66(6.4%)和 95(9.2%)例患者分别患有糖尿病。对于中间高血糖或糖尿病的诊断,41.7%的患者和 10.0%的患者的结果不一致。在 HbA1c≥6.5%但 OGTT 诊断无糖尿病的患者中,低 HbG、中 HbG 和高 HbG 组的比例分别为 0%、3.8%和 32.8%。相反,HbA1c<5.7%但 OGTT 异常的患者比例分别为 30.4%、11.1%和 0%。在检测 OGTT 诊断的糖尿病方面,HbA1c 的 AUROC 在中 HbG 组[0.874(0.816-0.931)]优于低 HbG 或高 HbG 组[0.628(0.489-0.768);P<0.01]。只有年龄与高 HbG 状态独立相关[10 年 OR:1.3(1.1-1.5);P<0.0001]。
血红蛋白糖化可能解释了 HbA1c 与 OGTT 用于诊断糖代谢异常时许多不一致的结果。